Knowledge Hub

Biological challenges to effective vaccines in the developing world

Authors:

Nicholas C. Grassly et al.

Vaccines & delivery devices Cholera

Safety and immunogenicity of novel adenovirus type 26– and modified vaccinia Ankara–vectored ebola Vaccines

Authors:

Iain D. Milligan et al.

Vaccines & delivery devices Ebola

Progress in introduction of pneumococcal conjugate vaccine — worldwide, 2000–2012

Authors:

Centers for Disease Control and Prevention (CDC)

Vaccines & delivery devices Pneumococcal disease

Identifying optimal vaccination strategies for serogroup A Neisseria Meningitidis Conjugate vaccine in the African meningitis belt

Authors:

Sara Tartof et al.

Vaccines & delivery devices Senegal Ethiopia Burkina Faso Africa HIB

13-Valent pneumo vaccine (PCV13) in children partially immunized with 7-valent pneumo vaccine

Authors:

Sven Arne Silfverdal et al.

Vaccines & delivery devices Sweden Pneumococcal disease

Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh

Authors:

Taufiqur R. Bhuiyan et al.

Vaccines & delivery devices Bangladesh Typhoid

ffectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case–control study

Authors:

Maria Y.T. Ichihara et al.

Vaccines & delivery devices Brazil Rotavirus

Hepatitis E vaccine: WHO position paper, May 2015 - Recommendations.

Authors:

World Health Organization (WHO)

Vaccines & delivery devices Hepatitis E

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Authors:

Tameris MD et al.

Vaccines & delivery devices South Africa TB

Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by tdap brand

Authors:

Koepke R et al.

Vaccines & delivery devices United States of America Tetanus Pertussis Diphtheria

Cholera vaccine: New preventive tool for endemic countries

Authors:

Vaccines & delivery devices India Cholera

Malaria vaccine: WHO position paper – May 2024

Authors:

World Health Organization (WHO)

Vaccines & delivery devices Malaria

A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus

Authors:

Vaccines & delivery devices Hepatitis E

Clinical experience with the meningococcal B vaccine, Bexsero®: Prospects for reducing the burden of meningococcal serogroup B disease

Authors:

Vaccines & delivery devices Uruguay United States of America Chile Canada Brazil Australia

Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction

Authors:

Vaccines & delivery devices Ghana Rotavirus

Smallpox vaccines: targets of protective immunity

Authors:

Bernard Moss

Vaccines & delivery devices Smallpox

Analysis of safety data in children after receiving two doses of ProQuad® (MMRV)

Authors:

Vaccines & delivery devices Measles

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

Authors:

Vaccines & delivery devices Malaria

Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use.

Authors:

Vaccines & delivery devices

Varicella and herpes zoster vaccines: WHO position paper, June 2014 - Recommendations.

Authors:

World Health Organization (WHO)

Vaccines & delivery devices Varicella

Knowledge Hub

Biological challenges to effective vaccines in the developing world

Safety and immunogenicity of novel adenovirus type 26– and modified vaccinia Ankara–vectored ebola Vaccines

Progress in introduction of pneumococcal conjugate vaccine — worldwide, 2000–2012

Identifying optimal vaccination strategies for serogroup A Neisseria Meningitidis Conjugate vaccine in the African meningitis belt

13-Valent pneumo vaccine (PCV13) in children partially immunized with 7-valent pneumo vaccine

Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh

ffectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case–control study

Hepatitis E vaccine: WHO position paper, May 2015 - Recommendations.

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by tdap brand

Cholera vaccine: New preventive tool for endemic countries

Malaria vaccine: WHO position paper – May 2024

A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus

Clinical experience with the meningococcal B vaccine, Bexsero®: Prospects for reducing the burden of meningococcal serogroup B disease

Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction

Smallpox vaccines: targets of protective immunity

Analysis of safety data in children after receiving two doses of ProQuad® (MMRV)

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use.

Varicella and herpes zoster vaccines: WHO position paper, June 2014 - Recommendations.

Filters

About

Knowledge Hub

Community

More